News & Press Releases Swedish
News & Press Releases English
Scandinavian ChemoTech and its CEO Mohan Frick participates and presents at the Emerging Medtech Summit in California, USA
Scandinavian ChemoTech obtains two patent approvals for the key features of the technical platform Tumour Specific Electroporation
Scandinavian ChemoTech expands its presence in the Philippines by signing a distribution agreement focusing on the public healthcare system
Chemotech Videos
Share Day in Gothenburg, November 4 2019
Share Day in Malmö on May 22, 2018
Share analysis ChemoTech Q2 2018
Our foundation
Our profound knowledge in Electroporation forms the starting point for the company’s existing product and R&D projects : IQwave™ specially desinged for both Dynamic-ElectroEnhanced Chemotherapy and the first generation Electrochemotherpy for the treatment of a range of different types of tumors.
Our research focus
Our aim is to document the effects of elctrochemotherapy for pain management for cancer patients, an area with significant unmet medical need.